Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 06-2011 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,847 | 834 | 1,656 | 1,492 | 1,334 |
| Marketable Securities | 6,752 | 458 | 1,431 | 3,401 | 3,680 |
| Inventories | 56 | 199 | 72 | 216 | 293 |
| Other current assets | 157 | 233 | 289 | 455 | 395 |
| TOTAL | $9,812 | $1,724 | $3,448 | $5,616 | $5,758 |
| Non-Current Assets | |||||
| PPE Net | 17 | 15 | 27 | 60 | 81 |
| Intangibles | 102 | 297 | 332 | 240 | 252 |
| TOTAL | $119 | $312 | $359 | $300 | $333 |
| Total Assets | $9,931 | $2,036 | $3,807 | $5,916 | $6,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 2 |
| Accounts payable and accrued liabilities | 78 | 20 | 97 | 137 | 187 |
| TOTAL | $495 | $457 | $391 | $922 | $527 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $495 | $457 | $391 | $922 | $527 |
| Shareholders' Equity | |||||
| Common Shares | 913 | 752 | 752 | 696 | 597 |
| Retained earnings | -17,731 | -19,078 | -17,241 | -13,313 | -10,241 |
| Other shareholders' equity | 483 | 483 | 483 | 483 | 483 |
| TOTAL | $9,436 | $1,579 | $3,416 | $4,994 | $5,564 |
| Total Liabilities And Equity | $9,931 | $2,036 | $3,807 | $5,916 | $6,091 |